ADAG
Price
$1.92
Change
+$0.02 (+1.05%)
Updated
Jun 27, 03:03 PM (EDT)
Capitalization
89.51M
61 days until earnings call
CRDF
Price
$3.13
Change
-$0.03 (-0.95%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
208.56M
34 days until earnings call
Interact to see
Advertisement

ADAG vs CRDF

Header iconADAG vs CRDF Comparison
Open Charts ADAG vs CRDFBanner chart's image
Adagene
Price$1.92
Change+$0.02 (+1.05%)
Volume$100
Capitalization89.51M
Cardiff Oncology
Price$3.13
Change-$0.03 (-0.95%)
Volume$5.49K
Capitalization208.56M
ADAG vs CRDF Comparison Chart in %
Loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAG vs. CRDF commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Buy and CRDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ADAG: $1.90 vs. CRDF: $3.16)
Brand notoriety: ADAG and CRDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 66% vs. CRDF: 56%
Market capitalization -- ADAG: $89.51M vs. CRDF: $208.56M
ADAG [@Biotechnology] is valued at $89.51M. CRDF’s [@Biotechnology] market capitalization is $208.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileCRDF’s FA Score has 0 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • CRDF’s FA Score: 0 green, 5 red.
According to our system of comparison, CRDF is a better buy in the long-term than ADAG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 4 TA indicator(s) are bullish while CRDF’s TA Score has 6 bullish TA indicator(s).

  • ADAG’s TA Score: 4 bullish, 5 bearish.
  • CRDF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRDF is a better buy in the short-term than ADAG.

Price Growth

ADAG (@Biotechnology) experienced а -2.56% price change this week, while CRDF (@Biotechnology) price change was +4.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

ADAG is expected to report earnings on Aug 27, 2025.

CRDF is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDF($209M) has a higher market cap than ADAG($89.5M). ADAG YTD gains are higher at: -4.523 vs. CRDF (-27.189). ADAG has higher annual earnings (EBITDA): -31.51M vs. CRDF (-51.7M). ADAG has more cash in the bank: 95.7M vs. CRDF (79.9M). CRDF has less debt than ADAG: CRDF (1.36M) vs ADAG (20.8M). ADAG has higher revenues than CRDF: ADAG (816K) vs CRDF (587K).
ADAGCRDFADAG / CRDF
Capitalization89.5M209M43%
EBITDA-31.51M-51.7M61%
Gain YTD-4.523-27.18917%
P/E RatioN/AN/A-
Revenue816K587K139%
Total Cash95.7M79.9M120%
Total Debt20.8M1.36M1,534%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGCRDF
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABIT0.05N/A
+3.96%
ATHENA BITCOIN GLOBAL
DNTUY22.060.40
+1.85%
Dentsu Group Inc.
OTSKY24.540.26
+1.07%
Otsuka Holdings Co. Ltd.
AXREF0.50N/A
+0.72%
Amarc Resources Ltd.
HTHIF28.02-0.22
-0.80%
Hitachi Ltd.

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and ENTA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and ENTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
-2.06%
ENTA - ADAG
24%
Poorly correlated
+2.60%
IBO - ADAG
24%
Poorly correlated
-4.35%
CRDF - ADAG
23%
Poorly correlated
+1.94%
CYBN - ADAG
22%
Poorly correlated
+3.87%
QTTB - ADAG
22%
Poorly correlated
-2.52%
More